Stocks and Investing
Stocks and Investing
Tue, March 19, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Mon, March 18, 2024
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
David Nierengarten Reiterated (TSVT) at Hold and Held Target at $5 on, Mar 18th, 2024
David Nierengarten of Wedbush, Reiterated "2seventy bio, Inc." (TSVT) at Hold and Held Target at $5 on, Mar 18th, 2024.
David has made no other calls on TSVT in the last 4 months.
There are 2 other peers that have a rating on TSVT. Out of the 2 peers that are also analyzing TSVT, 1 agrees with David's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Yaron Werber of "TD Cowen" Downgraded from Buy to Hold on, Wednesday, January 31st, 2024
This is the rating of the analyst that currently disagrees with David
- Daina Graybosch of "Leerink Partners" Upgraded from Hold to Buy and Increased Target to $18 on, Wednesday, January 31st, 2024
Contributing Sources